Annual Working Capital
$23.00 M
-$52.40 M-69.50%
December 31, 2022
Summary
- As of February 10, 2025, LMNL annual working capital is $23.00 million, with the most recent change of -$52.40 million (-69.50%) on December 31, 2022.
- During the last 3 years, LMNL annual working capital has fallen by -$25.68 million (-52.75%).
Performance
LMNL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$12.38 M
-$6.14 M-33.17%
June 30, 2023
Summary
- As of February 10, 2025, LMNL quarterly working capital is $12.38 million, with the most recent change of -$6.14 million (-33.17%) on June 30, 2023.
- Over the past year, LMNL quarterly working capital has dropped by -$14.79 million (-54.44%).
Performance
LMNL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
LMNL Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.5% | -54.4% |
| 3 y3 years | -52.8% | -0.7% |
| 5 y5 years | -20.2% | +11.1% |
LMNL Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.5% | at low | -83.6% | at low |
| 5 y | 5-year | -69.5% | at low | -86.1% | at low |
| alltime | all time | -69.5% | -136.8% | -86.1% | -234.4% |
Liminal BioSciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $12.38 M(-33.2%) |
| Mar 2023 | - | $18.52 M(-19.5%) |
| Dec 2022 | $23.00 M(-69.5%) | $23.00 M(-10.6%) |
| Sep 2022 | - | $25.72 M(-5.3%) |
| Jun 2022 | - | $27.16 M(-20.6%) |
| Mar 2022 | - | $34.20 M(-54.6%) |
| Dec 2021 | $75.40 M(+95.3%) | $75.40 M(-15.1%) |
| Sep 2021 | - | $88.85 M(+187.8%) |
| Jun 2021 | - | $30.87 M(+16.3%) |
| Mar 2021 | - | $26.55 M(-31.2%) |
| Dec 2020 | $38.61 M(-20.7%) | $38.61 M(+82.8%) |
| Sep 2020 | - | $21.12 M(+69.5%) |
| Jun 2020 | - | $12.46 M(-57.0%) |
| Mar 2020 | - | $29.00 M(-40.4%) |
| Dec 2019 | $48.68 M(+1197.0%) | $48.68 M(+15.2%) |
| Sep 2019 | - | $42.25 M(-32.1%) |
| Jun 2019 | - | $62.19 M(-3973.0%) |
| Mar 2019 | - | -$1.61 M(-142.8%) |
| Dec 2018 | $3.75 M(-87.0%) | $3.75 M(-71.1%) |
| Sep 2018 | - | $13.00 M(+16.7%) |
| Jun 2018 | - | $11.14 M(-51.2%) |
| Mar 2018 | - | $22.85 M(-20.7%) |
| Dec 2017 | $28.83 M(+20.7%) | $28.83 M(-38.2%) |
| Sep 2017 | - | $46.67 M(+243.1%) |
| Jun 2017 | - | $13.60 M(-21.1%) |
| Mar 2017 | - | $17.25 M(-27.8%) |
| Dec 2016 | $23.89 M(+5.8%) | $23.89 M(-22.9%) |
| Sep 2016 | - | $30.96 M(-43.7%) |
| Jun 2016 | - | $55.02 M(+82.8%) |
| Mar 2016 | - | $30.10 M(+33.3%) |
| Dec 2015 | $22.57 M(+393.5%) | $22.57 M(-37.4%) |
| Sep 2015 | - | $36.03 M(-26.0%) |
| Jun 2015 | - | $48.69 M(-892.3%) |
| Mar 2015 | - | -$6.15 M(-234.3%) |
| Dec 2014 | $4.57 M(-54.1%) | $4.57 M(-139.4%) |
| Sep 2014 | - | -$11.61 M(-2.0%) |
| Jun 2014 | - | -$11.84 M(-696.0%) |
| Mar 2014 | - | $1.99 M(-80.1%) |
| Dec 2013 | $9.97 M(+133.6%) | $9.97 M(-499.5%) |
| Sep 2013 | - | -$2.50 M(-200.8%) |
| Jun 2013 | - | $2.48 M(-27.6%) |
| Mar 2013 | - | $3.42 M(-19.9%) |
| Dec 2012 | $4.27 M(-150.5%) | $4.27 M(-148.1%) |
| Sep 2012 | - | -$8.88 M(+8.4%) |
| Jun 2012 | - | -$8.19 M(-28.2%) |
| Mar 2012 | - | -$11.42 M(+35.1%) |
| Dec 2011 | -$8.45 M(+52.0%) | -$8.45 M(-49.2%) |
| Sep 2011 | - | -$16.63 M(+15.8%) |
| Jun 2011 | - | -$14.36 M(-6.1%) |
| Mar 2011 | - | -$15.29 M(+175.0%) |
| Dec 2010 | -$5.56 M | -$5.56 M(+18.2%) |
| Sep 2010 | - | -$4.70 M(-2861.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $170.30 K(-67.1%) |
| Mar 2010 | - | $517.70 K(-107.0%) |
| Dec 2009 | -$7.40 M(+74.9%) | -$7.40 M(+16.4%) |
| Sep 2009 | - | -$6.36 M(-22.3%) |
| Jun 2009 | - | -$8.18 M(+41.6%) |
| Mar 2009 | - | -$5.78 M(+36.6%) |
| Dec 2008 | -$4.23 M(+25.4%) | -$4.23 M(+690.8%) |
| Sep 2008 | - | -$534.80 K(-88.6%) |
| Jun 2008 | - | -$4.71 M(-35.2%) |
| Mar 2008 | - | -$7.27 M(+115.4%) |
| Dec 2007 | -$3.37 M(-131.9%) | -$3.37 M(-781.2%) |
| Sep 2007 | - | $495.20 K(-75.9%) |
| Jun 2007 | - | $2.05 M(-70.4%) |
| Mar 2007 | - | $6.94 M(-34.4%) |
| Dec 2006 | $10.58 M(+42.1%) | $10.58 M(-734.3%) |
| Sep 2006 | - | -$1.67 M(-138.5%) |
| Jun 2006 | - | $4.34 M(+202.6%) |
| Mar 2006 | - | $1.43 M(-80.8%) |
| Dec 2005 | $7.45 M(+113.6%) | $7.45 M(+50.5%) |
| Sep 2005 | - | $4.95 M(-29.9%) |
| Jun 2005 | - | $7.06 M(+251.4%) |
| Mar 2005 | - | $2.01 M(-42.4%) |
| Dec 2004 | $3.49 M(-77.0%) | $3.49 M(-60.9%) |
| Sep 2004 | - | $8.91 M(-26.3%) |
| Jun 2004 | - | $12.08 M(-10.3%) |
| Mar 2004 | - | $13.47 M(-11.3%) |
| Dec 2003 | $15.19 M(+11.5%) | $15.19 M(+161.4%) |
| Sep 2003 | - | $5.81 M(-36.3%) |
| Jun 2003 | - | $9.12 M(-23.3%) |
| Mar 2003 | - | $11.90 M(-12.7%) |
| Dec 2002 | $13.63 M(+119.2%) | $13.63 M(-16.9%) |
| Sep 2002 | - | $16.40 M(-12.8%) |
| Jun 2002 | - | $18.80 M(+218.9%) |
| Mar 2002 | - | $5.90 M(-5.2%) |
| Dec 2001 | $6.22 M(+173.2%) | $6.22 M(+11.5%) |
| Sep 2001 | - | $5.58 M(+1325.8%) |
| Jun 2001 | - | $391.10 K(-64.0%) |
| Mar 2001 | - | $1.09 M(-52.3%) |
| Dec 2000 | $2.28 M(-572.7%) | $2.28 M(-46.0%) |
| Sep 2000 | - | $4.22 M(+1982.5%) |
| Jun 2000 | - | $202.50 K(-85.3%) |
| Mar 2000 | - | $1.38 M(-386.0%) |
| Dec 1999 | -$481.40 K(-113.1%) | -$481.40 K(-29.4%) |
| Sep 1999 | - | -$681.40 K(-143.8%) |
| Jun 1999 | - | $1.56 M(+369.8%) |
| Mar 1999 | - | $331.30 K(-91.0%) |
| Dec 1998 | $3.68 M(+182.6%) | $3.68 M(-43.9%) |
| Sep 1998 | - | $6.56 M(-2024.8%) |
| Jun 1998 | - | -$340.90 K(-153.9%) |
| Mar 1998 | - | $632.20 K(+29.4%) |
| Dec 1997 | - | $488.40 K |
| Sep 1997 | $1.30 M | - |
FAQ
- What is Liminal BioSciences annual working capital?
- What is the all time high annual working capital for Liminal BioSciences?
- What is Liminal BioSciences annual working capital year-on-year change?
- What is Liminal BioSciences quarterly working capital?
- What is the all time high quarterly working capital for Liminal BioSciences?
- What is Liminal BioSciences quarterly working capital year-on-year change?
What is Liminal BioSciences annual working capital?
The current annual working capital of LMNL is $23.00 M
What is the all time high annual working capital for Liminal BioSciences?
Liminal BioSciences all-time high annual working capital is $75.40 M
What is Liminal BioSciences annual working capital year-on-year change?
Over the past year, LMNL annual working capital has changed by -$52.40 M (-69.50%)
What is Liminal BioSciences quarterly working capital?
The current quarterly working capital of LMNL is $12.38 M
What is the all time high quarterly working capital for Liminal BioSciences?
Liminal BioSciences all-time high quarterly working capital is $88.85 M
What is Liminal BioSciences quarterly working capital year-on-year change?
Over the past year, LMNL quarterly working capital has changed by -$14.79 M (-54.44%)